PrimeInvestor - Articles and Reports

Entering a stock at peak valuation - 5 questions to ask
Stocks
N V Chandrachoodamani

Entering a stock at peak valuation? – 5 questions to ask

When markets make merry, many stocks have seemingly compelling stories even for entering at peak valuation. And the market is fine with stretched valuations to accommodate such stories. In other words, every market-favoured stock appears to scream – buy me at any price.

But when challenges emerge, the same market starts reacting so sharply that investors who bought into the story midway start making losses. Yes, there isn’t a bigger disaster for stock market investors than earnings and PE multiples contracting together.

Read More
Why banking is a fragile business
Stocks
R Balakrishnan

Why banking is a fragile business

The recent furore surrounding the failure of Silicon Valley Bank in the US has exposed that while banking is a favourite sector with stock market investors, the fragility of the banking business is far from well-understood. Banks are held up as the engines of economic growth. Whichever sector grows, the banking sector ultimately gains. Banks are also accorded a higher valuation than most sectors during bull phases. In good times, banks made up a 40% plus weight in our leading stock market indices.

Read More
Prime stock: An averaging call on this fashion player
Stocks
N V Chandrachoodamani

Prime Stock: An averaging call on this fashion player

In February last year, we had issued a buy call on the stock of a premier fashion player housing a vast number of national brands. The steps this company had taken to expand its offering range, a return of focus on margins, and the consumption promise all propelled the call. the stock rallied handsomely as well, post our call.
However, owing to two factors, the stock has since given up nearly 40% from its high and is currently about 25% below our original call price.

Read More
Prime stock alert: Shifting this auto stock from HOLD to BUY
Stocks
N V Chandrachoodamani

Prime Stock alert: Shifting this auto stock from HOLD to BUY

Indian markets have corrected about 10% (Nifty 50) from the last peak in December 2022. But many stocks have fallen much more than the bellwether index. This has provided an opportunity to revisit some of our recommended stocks – to either identify averaging opportunities or move them to a BUY from a HOLD.

Premium article available only to subscribers.

Read More
How to pick stocks in 2023
Stocks
N V Chandrachoodamani

How to pick stocks in 2023

When we published our equity market outlook for 2023, we had mentioned where pockets of opportunity could be found. The correction the market is going through provides fertile grounds for stock picking. So here, we tell you how to pick stocks in 2023, in those pockets that we had noted. We do this using our Stock Screener.

Read More
Prime stock recommendation - a promising play on food security
Stocks
PrimeInvestor Research Team

Prime Stock recommendation: A promising play on food security

Recent instances of countries rationing food supplies on import disruptions and grappling with hyper-inflation, have prompted governments the world over to refocus on food security. With limited supply of arable land and water, the key to achieving food security lies in improving crop yields. In India, there’s a crying need to improve yields not only to secure food supplies for the domestic population, but also to cater to global export opportunities for farm products, that are at an inflection point. Companies engaged in crop protection, fertilizer and hybrid seeds are positioned to make the most of these tailwinds.
But if you’re an Indian investor looking to make a long-term bet on this theme, your options aren’t very many. There are about 20 listed companies in the fertilizer space. But the sector makes for a poor investment because of whimsical government policies that hamper growth and profitability. Listed crop protection and seed companies offer superior options. Listed agrochem players offer choices from micro to large players, with differing business models that focus on generic agrochemicals, interm

Premium article available only to subscribers.

Read More
Technical outlook: Can the Nifty 50 slide further?
Markets
B Krishnakumar

Technical outlook: Can the Nifty 50 slide further?

In the past couple of posts on the Nifty 50 outlook, we have been voicing a bearish view for the Nifty 50 index. This has played out as per expectations. The index almost achieved the first target of 17,150-17,200 that was mentioned a couple of posts ago. In the previous update, we had mentioned the possibility of a slide to the 16,700-16,900 zone.
Let us assess if this target is likely to be achieved or not.

Read More
Prime stock update: Are we still sweet on this sugar maker?
Stocks
Pavithra Jaivant

Prime stock update: Are we still sweet on this sugar maker?

In August 2021, we recommended a sugar manufacturer, well placed to play the ethanol opportunity that was set to change the dynamics of the sugar sector in India. 18 months down the line, the ethanol opportunity has played out as we expected and we have more clarity on this front. But at the same time, stock returns for our chosen candidate stand at just ~5% since our ‘BUY’ recommendation even though it rallied over 30% and also fell by almost 20% in the interim. We think, this calls for an update.

Premium article available only to subscribers.

Read More
Prime stocks update: An exit call on an insurance stock
Stocks
N V Chandrachoodamani

Prime stocks update: An exit call on an insurance stock

In April 2022, we had issued a buy recommendation on a general insurance player, as both the industry and the company itself were emerging from the Covid-driven impact and were poised for growth. Since then, however, the insurance sector has lost market favour as growth has not panned out as expected.

Premium article available only to subscribers.

Read More
Moving-this-biotech-stock-from-BUY-to-a-HOLD
Stocks
N V Chandrachoodamani

Prime Stocks update: Moving this biotech stock from BUY to a HOLD

When we gave the call of this R&D focused company engaged in the manufacture of enzymes and probiotics, the company had Covid-related challenges but showed promise of growth. It was later also pulled down by consolidation of acquisitions and costs related to new product launches. We therefore knew that the call would take longer to pay off.  The stock went through a significant correction after our initial recommendation as earnings disappointed.

Premium article available only to subscribers.

Read More
Adani stocks and index funds: cause for concern?
Commentary
Aarati Krishnan

Adani stocks and index funds: cause for concern?

After the Hindenburg bombshell tanked Adani stocks, the faith that some investors placed in index investing seems to have been shaken. With the Nifty 50 and Nifty Next 50 featuring seven Adani group stocks between them, PrimeInvestor received many queries soon after the news broke. 

Read More
Prime Stock update: Prospects brighten for our small finance bank call
Stocks
N V Chandrachoodamani

Prime Stock update: Prospects brighten for our small finance bank call

Covid proved be an ultimate stress test for Small Finance Banks (SFBs). As SFBs largely cater to low income borrowers comprising small businesses, small vehicle owners and other self-employed categories including micro-finance, they were among the most Covid-sensitive sectors.

Premium article available only to subscribers.

Read More
Login to your account
OR

Become a PrimeInvestor!

Get access to fresh stocks and mutual funds recommendations.

or